PathRight Medical completed two clinical studies in cooperation with Mayo Clinic, enrolling over 100 men in total. The first trial compared RestoreX use for 30, 60, or 90 minutes per day with a control group that received no treatment.
Dr Trost developed a video for men using RestoreX to treat Peyronie’s disease. Its second section, about freeing penile and scrotal skin, also applies to men using RestoreX for lengthening and begins two minutes into the video.
PathRight Medical believes RestoreX provides significant advantages relative to surgery, injections and other conservative therapies including traction devices available today. The table below compares RestoreX to first generation traction systems:
PathRight Medical was formed in 2015 to improve the lives of men with Peyronie’s disease or side effects associated with urological surgeries or chronic disease. The company developed RestoreX in cooperation with Mayo Clinic.
PathRight Medical meaningfully improves the lives of men with Peyronie’s disease or those with side effects associated with urological surgeries or chronic disease.
RestoreX is used for the treatment of Peyronie’s disease and to correct or prevent lost penile length resulting from urological surgeries and treatments or chronic disease.